Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at or call 800-767-3771 ext.  9339.

HCA Holdings Inc. (HCA - Snapshot Report) announced its preliminary financial and operating results for the first quarter of 2013. HCA expects to record income before income tax to be approximately $639 million, down 33.6% year over year.

HCA’s adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) projection for the first quarter of 2013 stands at $1.568 billion, down 14% year over year. Depreciation and amortization is expected to be $424 million, up 1.7% year over year. Interest expense is expected to be $472 million, up 6.8% year over year.

The decline in results came from a sluggish growth rate of admissions and low outpatient volumes during the second half of the quarter.

The first quarter results are expected to include pretax losses on sale of facilities of $16 million or 2 cents per share and a pretax loss on retirement of debt of nearly $17 million or 3 cents per share. The first quarter of 2012 results included net favorable Medicare adjustments that contributed $188 million to revenues, $170 million to adjusted EBITDA and 22 cents to earnings per share.

HCA expects revenues of $ 8.440 billion in the first quarter of 2013, up 0.4% from $8.405 billion in the year-ago quarter. However, revenues are significantly lower than the Zacks Consensus Estimate of $9.5 billion.
Meanwhile, same facility admissions increased 0.1% year over year in the first quarter of 2013 compared to a 3.2% increase in the year-ago quarter. Same facility equivalent admissions decreased 0.7% year over year as compared to a 4.8% increase in the year-ago quarter.

Managed care/commercial same facility equivalent admissions declined 4.6% in the current quarter as compared to a 2.8% increase in the year-ago quarter, resulting in a moderation in volume growth trends.

Additionally, same facility revenue per equivalent admission is expected to increase about 0.8% year over year in the first quarter of 2013. Same facility revenue per equivalent admission would have increased 3.5% year over year in the first quarter of 2013, had it excluded the net favorable Medicare adjustments in the first quarter of 2012.

Same facility emergency room visits improved 3.8% year over year in the first quarter of 2013. Same facility inpatient surgeries decreased 2.6% year over year in the first quarter of 2013. Same facility outpatient surgeries decreased 4.3% year over year in the quarter.

HCA is scheduled to report its first quarter 2013 complete financial results on May 2, 2013. Among others from the industry Tenet Healthcare Corp. (THC - Analyst Report), Health Management Associates Inc. and Lifepoint Hospitals Inc. (LPNT - Snapshot Report) are expected to report their first quarter 2013 results shortly.

HCA currently carries a Zacks Rank #3 (Hold).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 33.01 +7.28%
NOAH HOLDING NOAH 13.84 +4.10%
VALEO SA SPO VLEEY 67.91 +3.95%
DIXIE GROUP DXYN 14.58 +3.70%